Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Proponents often emphasize the possibility for significant therapeutic gains, principally in conditions where conventional treatments have proven inadequate. However, this is to evaluate the substantial financial expenditure associated with CPI st